Venous thromboembolism in patients with intracranial haemorrhage

 

Notes

^* A full list of RIETE investigators is given in the Appendix.

• References

• 1 Kearon C, Kahn SR, Agnelli G. et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8^th edition). Chest 2008; 133: 454S-545S.
• 2 Nieto JA, Bruscas MJ, Ruiz-Ribó D. et al. Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome. J Thromb Haemost 2006; 4: 2367-2373.
• 3 Ruíz-Giménez N, Suárez C, González R. et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26-31.
• 4 Vasco B, Villalba JC, Lopez-Jimenez L. et al. Venous thromboembolism in nonagenarians. Findings from the RIETE Registry. Thromb Haemost 2009; 101: 1112-1118.
• 5 Bailey RD, Hart RG, Benavente O. et al. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracerebral hemorrhage. Neurology 2001; 56: 773-777.
• 6 Vermeer SE, Algra A, Franke CL. et al. Long-term prognosis after recovery from primary intracerebral haemorrhage. Neurology 2002; 59: 205-209.
• 7 Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995; 26: 1471-1477.